Search research articles
Contact Us
Filters
Showing results (191-200 of 664) with videos related to
Page
of 67
Sort By:
Frontiers in Genetics
|
February 5, 2026
<i>CDKN2AIPNL</i>: a potential pan-cancer biomarker
Yulin Yuan, Sheng-Xiao Ma, Heshi Liu, et al.
World Journal of Gastroenterology
|
March 7, 2008
Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901
Zheng-Hao Deng, Ji-Fang Wen, Jing-He Li, et al.
Neoplasia (New York, N.Y.)
|
March 18, 2010
RPL41, a small ribosomal peptide deregulated in tumors, is essential for mitosis and centrosome integrity
Shan Wang, Jianmin Huang, Jie He, et al.
Drug Discovery Today
|
March 13, 2025
Leveraging machine learning for drug repurposing in rheumatoid arthritis
Qin-Yi Su, Yi-Xin Cao, He-Yi Zhang, et al.
Acta Biochimica Et Biophysica Sinica
|
March 7, 2006
Enhancement of metastatic and invasive capacity of gastric cancer cells by transforming growth factor-beta1
Kuan-Song Wang, Zhong-Liang Hu, Jing-He Li, et al.
Frontiers in Pediatrics
|
September 16, 2022
Case report: Glucose 6-phosphate-isomerase deficiency combine with avascular necrosis of bilateral femoral head
Zhenqi Song, Kongjian Wang, Djandan Tadum Arthur, et al.
Acta Crystallographica. Section E, Crystallographic Communications
|
September 13, 2021
Synthesis and crystal structure of poly[(3-amino-1,2,4-triazole)(μ<sub>3</sub>-1<i>H</i>-benzimidazole-5,6-di-carboxyl-ato)cobalt(II)]
Chen Zhao, Yi Li, Jin-Sheng Xiao, et al.
The Journal of Biological Chemistry
|
July 23, 2003
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
Shiguang Liu, Rong Guo, Leigh G Simpson, et al.
Frontiers in Immunology
|
September 2, 2022
Predictive value of drug efficacy by M6A modification patterns in rheumatoid arthritis patients
Shan Song, Rong Zhao, Jun Qiao, et al.
British Journal of Pharmacology
|
January 11, 2017
Genistein and tyrphostin AG556 decrease ultra-rapidly activating delayed rectifier K<sup>+</sup> current of human atria by inhibiting EGF receptor tyrosine kinase
Guo-Sheng Xiao, Yan-Hui Zhang, Wei Wu, et al.
Page
of 67
Search research articles
Search
Showing results (191-200 of 664) with videos related to
Sort By:
Page
of 67
Frontiers in Genetics
|
February 5, 2026
<i>CDKN2AIPNL</i>: a potential pan-cancer biomarker
Yulin Yuan, Sheng-Xiao Ma, Heshi Liu, et al.
World Journal of Gastroenterology
|
March 7, 2008
Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901
Zheng-Hao Deng, Ji-Fang Wen, Jing-He Li, et al.
Neoplasia (New York, N.Y.)
|
March 18, 2010
RPL41, a small ribosomal peptide deregulated in tumors, is essential for mitosis and centrosome integrity
Shan Wang, Jianmin Huang, Jie He, et al.
Drug Discovery Today
|
March 13, 2025
Leveraging machine learning for drug repurposing in rheumatoid arthritis
Qin-Yi Su, Yi-Xin Cao, He-Yi Zhang, et al.
Acta Biochimica Et Biophysica Sinica
|
March 7, 2006
Enhancement of metastatic and invasive capacity of gastric cancer cells by transforming growth factor-beta1
Kuan-Song Wang, Zhong-Liang Hu, Jing-He Li, et al.
Frontiers in Pediatrics
|
September 16, 2022
Case report: Glucose 6-phosphate-isomerase deficiency combine with avascular necrosis of bilateral femoral head
Zhenqi Song, Kongjian Wang, Djandan Tadum Arthur, et al.
Acta Crystallographica. Section E, Crystallographic Communications
|
September 13, 2021
Synthesis and crystal structure of poly[(3-amino-1,2,4-triazole)(μ<sub>3</sub>-1<i>H</i>-benzimidazole-5,6-di-carboxyl-ato)cobalt(II)]
Chen Zhao, Yi Li, Jin-Sheng Xiao, et al.
The Journal of Biological Chemistry
|
July 23, 2003
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
Shiguang Liu, Rong Guo, Leigh G Simpson, et al.
Frontiers in Immunology
|
September 2, 2022
Predictive value of drug efficacy by M6A modification patterns in rheumatoid arthritis patients
Shan Song, Rong Zhao, Jun Qiao, et al.
British Journal of Pharmacology
|
January 11, 2017
Genistein and tyrphostin AG556 decrease ultra-rapidly activating delayed rectifier K<sup>+</sup> current of human atria by inhibiting EGF receptor tyrosine kinase
Guo-Sheng Xiao, Yan-Hui Zhang, Wei Wu, et al.
Page
of 67